Labiotech.eu

News and Trends 6 Feb 2018

New Artificial Intelligence Test for Leukemia Now Available in Europe

Sophia Genetics has received a CE-IVD mark for its molecular diagnostics test, which will improve the detection of leukemia. Swiss company Sophia Genetics is a leader in the field of data-driven medicine, with its artificial intelligence (AI) technology already been used to analyze the next-generation sequencing data of over 160,000 patients’ around the world. Today, the company […]

February 6, 2018 - 3 minutesmins - By Alex Dale

In Depth 6 Feb 2018

CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?

The emergence of CRISPR/Cas9 technologies has enabled almost unlimited gene editing opportunities. Not only could it be used as a therapeutic tool, the genome editing tool could kickstart a revolution in drug discovery. To date, much of the attention on CRISPR/Cas9, which stands for clustered regularly interspaced short palindromic repeats, has revolved around its potential as […]

February 6, 2018 - 9 minutesmins - By Melanie De Almeida

balmes transplantation kidney disorders 1

News and Trends 6 Feb 2018

Say Hello to a New Biotech Striving to Prevent Kidney Damage During Surgery

Balmes Transplantation has raised €700,000 in seed funding to run a proof-of-concept study to test its drug combination for kidney damage. Balmes Transplantation is a young biotech in Marseille, France, that develops combination therapies for a common complication associated with kidney transplants and heart surgery. The biotech has raised a €700,000 seed funding from top company executives and angel […]

February 6, 2018 - 3 minutesmins - By Alex Dale

News and Trends 5 Feb 2018

New Antiviral for RSV Lung Infections Shows Promise in Phase IIa

ReViral’s candidate RV521 showed its potential for the treatment of respiratory syncytial virus (RSV) infections by reducing viral load and mucus levels. London-based biotech ReViral discovers and develops antiviral drugs, focusing particularly on the treatment of diseases caused by the respiratory syncytial virus (RSV). The biotech’s candidate, RV521, has undergone a Phase IIa clinical trial during […]

February 5, 2018 - 3 minutesmins - By Alex Dale

lig biowise diagnostics antimicrobial resistance

More News! 5 Feb 2018

A DNA-Based Diagnostic Company Rakes in £1.8M to Combat Antimicrobial Resistance

A new molecular diagnostics company, LIG Biowise, has just closed a £1.8M Series A fundraising round in its effort to combat antimicrobial resistance. Based in Manchester, LIG Biowise, is working on a DNA-based diagnostic to catch antibiotic resistant infections early. The company has now closed a Series A of £1.8M (€2.0M), led by Hong Kong-based Phoenix Bridge, to fund […]

February 5, 2018 - 1 minutemin - By Evelyn Warner

Deconstructing patterns exhibition francis crick institute

News and Trends 3 Feb 2018

Deconstructing Patterns: First Science and Art Exhibition Opens at the Francis Crick Institute

Deconstructing patterns, the first exhibition of its kind at the Francis Crick Institute, is the result of months of collaborations between scientists and artists. I got a chance to see it at the opening earlier this week. The new exhibition at the Francis Crick Institute puts into perspective the groundbreaking research happening in the scientists’ […]

February 3, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Feb 2018

The Success Rate of Clinical Trials Is Higher than We Thought

Instead of less than 10% of drugs reaching the market, a new study has found that almost 15% of new compounds pass clinical trials – which still suggests that it is pretty tough. Clinical trials give us a chance to test how a new drug or therapy interacts with the body and whether it is […]

February 2, 2018 - 3 minutesmins - By Alex Dale

Startup Scout 2 Feb 2018

This French Biotech’s Software Helps Drugs to Succeed in the Clinic

We’re in the French region of Alsace to visit BioNext, which develops software to help pharma and biotech companies to avoid pursuing flawed drug candidates. Mission: So far, BioNext has developed two tools that allow companies developing drugs to take a closer look at the target that they want to manipulate. Target Analysis identifies macromolecules that have specific interaction […]

February 2, 2018 - 1 minutemin - By Alex Dale

News and Trends 1 Feb 2018

3D Printing with Living Cells Could Revolutionize Tissue Engineering

Scientists at the University of Twente have managed to 3D print structures with living cells, which could boost the field of tissue engineering. Researchers at the University of Twente in the Netherlands have used a technique called ‘in-air microfluidics’ to 3D print structures that contain living cells. The work, which was published in Science Advances, allows […]

February 1, 2018 - 3 minutesmins - By Alex Dale

News and Trends 1 Feb 2018

New Diagnostic Tests On the Way as Qiagen Snaps Up a Spanish Biotech

Qiagen will acquire Spanish biotech STAT-Dx for up to €153M – more than 3 times the total funding it has raised so far – to produce fast and effective diagnostic tests for infections and cancer. Molecular diagnostics company Qiagen has agreed to acquire STAT-Dx, a Spanish biotech that focuses on developing tools to provide fast […]

February 1, 2018 - 3 minutesmins - By Alex Dale

cognitive disorders syndesi therapeutics 1

News and Trends 1 Feb 2018

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

Syndesi Therapeutics has been formed by UCB and a group of investors, including Novo Seeds and V-Bio to develop a group of compounds for cognitive disorders caused by diseases like Alzheimer’s. Syndesi Therapeutics will use of Belgian biotech UCB’s expertise in drug discovery for neurological conditions to develop new therapies in cognitive disorders using a new […]

February 1, 2018 - 3 minutesmins - By Alex Dale

News and Trends 31 Jan 2018

Your Pee Could Be Used to Build an Artificial Adrenal Gland

Scientists have started generating artificial glands using cells derived from urine, which will allow the study of adrenal disorders that affect growth, development, and metabolism. Researchers at Queen Mary University of London have used cells in urine to begin generating an artificial adrenal gland that could be used to treat adrenal gland disorders. The study, published in Cell Reports, […]

January 31, 2018 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

New Artificial Intelligence Test for Leukemia Now Available in Europe

CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?

Say Hello to a New Biotech Striving to Prevent Kidney Damage During Surgery

New Antiviral for RSV Lung Infections Shows Promise in Phase IIa

A DNA-Based Diagnostic Company Rakes in £1.8M to Combat Antimicrobial Resistance

Deconstructing Patterns: First Science and Art Exhibition Opens at the Francis Crick Institute

The Success Rate of Clinical Trials Is Higher than We Thought

This French Biotech’s Software Helps Drugs to Succeed in the Clinic

3D Printing with Living Cells Could Revolutionize Tissue Engineering

New Diagnostic Tests On the Way as Qiagen Snaps Up a Spanish Biotech

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

Your Pee Could Be Used to Build an Artificial Adrenal Gland

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!